ABTXInvestor Events•businesswire•
Autobahn Therapeutics to Participate in Multiple Upcoming Investor Conferences
Sentiment:Negative (20)
Summary
SAN DIEGO--(BUSINESS WIRE)--Autobahn Therapeutics, a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders, today announced that management will participate in the following upcoming investor conferences in September: 2025 Cantor Global Healthcare Conference Investor Meetings: Wednesday, September 3, 2025 Location: New York, NY 2025 BofA Healthcare Trailblazers Private Company Conference Investor Meetings: Wednesday, Septe
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 25, 2025 by businesswire